Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Palifosfamide

EU orphan designation number: EU/3/08/584   
Active ingredient: Palifosfamide
Indication: Treatment of soft tissue sarcoma
Sponsor: Ziopharm Oncology Limited
3rd Floor, 24 Chiswell Street, London EC1Y 4YX, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/12/2008 Centralised Orphan - Designation EMEA/OD/044/08 (2008)8094 of 03/12/2008